Your browser doesn't support javascript.
Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products.
Schräder, Tobias; Koch, Julia; Ross, Rachael; Schäfer, Wolfram; Keiner, Björn; Roth, Nathan J; Widmer, Eleonora.
  • Schräder T; Global Pathogen Safety (GPS), CSL Behring, USA.
  • Koch J; CSL Behring GmbH, Marburg, Germany.
  • Ross R; Global Pathogen Safety (GPS), CSL Behring, USA.
  • Schäfer W; CSL Behring GmbH, Marburg, Germany.
  • Keiner B; Global Pathogen Safety (GPS), CSL Behring, USA.
  • Roth NJ; CSL Behring (Australia) Pty Ltd, Broadmeadows, Victoria, Australia.
  • Widmer E; Global Pathogen Safety (GPS), CSL Behring, USA.
Transfusion ; 60(6): 1334-1335, 2020 06.
Article in English | MEDLINE | ID: covidwho-624209
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasma / Biological Products / Pharmaceutical Preparations / Transmissible gastroenteritis virus / Virus Inactivation / Manufactured Materials Type of study: Experimental Studies / Prognostic study Limits: Animals / Humans Language: English Journal: Transfusion Year: 2020 Document Type: Article Affiliation country: Trf.15850

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasma / Biological Products / Pharmaceutical Preparations / Transmissible gastroenteritis virus / Virus Inactivation / Manufactured Materials Type of study: Experimental Studies / Prognostic study Limits: Animals / Humans Language: English Journal: Transfusion Year: 2020 Document Type: Article Affiliation country: Trf.15850